{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T12:46:07Z","timestamp":1785329167001,"version":"3.55.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug Saf"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1007\/s40264-013-0017-y","type":"journal-article","created":{"date-parts":[[2013,1,31]],"date-time":"2013-01-31T07:22:31Z","timestamp":1359616951000},"page":"83-91","source":"Crossref","is-referenced-by-count":8,"title":["Malaria Prophylaxis in Patients with Renal Impairment"],"prefix":"10.1007","volume":"36","author":[{"given":"Sabine","family":"Amet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Zimner-Rapuch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Launay-Vacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Janus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilbert","family":"Deray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,2,1]]},"reference":[{"issue":"1","key":"17_CR1","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.cll.2009.10.001","volume":"30","author":"LS Garcia","year":"2010","unstructured":"Garcia LS. Malaria. Clin Lab Med. 2010;30(1):93\u2013129.","journal-title":"Clin Lab Med"},{"issue":"4","key":"17_CR2","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1365-3156.2006.01579.x","volume":"11","author":"M Kihara","year":"2006","unstructured":"Kihara M, Carter JA, Newton CR. The effect of Plasmodium falciparum on cognition: a systematic review. Trop Med Int Health. 2006;11(4):386\u201397.","journal-title":"Trop Med Int Health"},{"key":"17_CR3","unstructured":"WHO. World malaria report 2011. http:\/\/www.who.int\/malaria\/world_malaria_report_2011\/burdenestimatesbriefing2011.pdf . Accessed 12 Jun 2012."},{"key":"17_CR4","first-page":"1840","volume":"6","author":"I Rossi","year":"2010","unstructured":"Rossi I, Dacremont V, Peytremann-Bridevaux I. Prevention of malaria in travellers: which antimalarial is best? Rev Med Suisse. 2010;6:1840.","journal-title":"Rev Med Suisse"},{"key":"17_CR5","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1186\/1471-2334-10-330","volume":"10","author":"V Field","year":"2010","unstructured":"Field V, Gautret P, Schlagenhauf P, et al. Travel and migration associated infectious diseases morbidity in Europe, 2008. BMC Infect Dis. 2010;10:330.","journal-title":"BMC Infect Dis"},{"key":"17_CR6","unstructured":"WHO. Malaria. In: International travel and health 2010. Geneva: WHO, 2010. http:\/\/www.who.int\/ith\/ITH2010chapter7.pdf . Accessed 27 Dec 2012."},{"key":"17_CR7","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1186\/1475-2875-9-366","volume":"9","author":"SD Fernando","year":"2010","unstructured":"Fernando SD, Rodrigo C, Rajapakse S. The \u2018hidden\u2019 burden of malaria: cognitive impairment following infection. Malar J. 2010;9:366.","journal-title":"Malar J"},{"key":"17_CR8","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1001\/jama.298.17.2038","volume":"298","author":"J Coresh","year":"2007","unstructured":"Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298:2038\u201347.","journal-title":"JAMA"},{"key":"17_CR9","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.critrevonc.2008.09.012","volume":"70","author":"V Launay-Vacher","year":"2009","unstructured":"Launay-Vacher V, Spano JP, Janus N, et al. Renal insufficiency and anticancer drugs in elderly cancer patients: a subgroup analysis of the IRMA study. Crit Rev Oncol Hematol. 2009;70:124\u201333.","journal-title":"Crit Rev Oncol Hematol"},{"key":"17_CR10","volume-title":"GPR: antibiotiques et antifongiques. 3rd edition. Guide de prescription des m\u00e9dicaments chez le patient insuffisant r\u00e9nal","author":"S Karie","year":"2008","unstructured":"Karie S, Launay-Vacher V, Deray G. GPR: antibiotiques et antifongiques. 3rd edition. Guide de prescription des m\u00e9dicaments chez le patient insuffisant r\u00e9nal. Paris: Meditions International; 2008."},{"issue":"17","key":"17_CR11","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1001\/jama.298.17.2038","volume":"298","author":"J Coresh","year":"2007","unstructured":"Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298(17):2038\u201347.","journal-title":"JAMA"},{"key":"17_CR12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","volume":"16","author":"DW Cockcroft","year":"1976","unstructured":"Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31\u201341.","journal-title":"Nephron"},{"key":"17_CR13","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","volume":"130","author":"AS Levey","year":"1999","unstructured":"Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461\u201370.","journal-title":"Ann Intern Med"},{"key":"17_CR14","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1681\/ASN.2004070549","volume":"16","author":"M Froissart","year":"2005","unstructured":"Froissart M, Rossert J, Jacquot C, et al. Predictive performance of the modification of diet in renal disease and Cockcroft-Gault equations for estimating renal function. J Am Soc Nephrol. 2005;16:763\u201373.","journal-title":"J Am Soc Nephrol"},{"key":"17_CR15","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0272-6386(02)70081-4","volume":"39","author":"National Kidney Foundation","year":"2002","unstructured":"National Kidney Foundation. K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39:S1\u2013266.","journal-title":"Am J Kidney Dis"},{"key":"17_CR16","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1111\/j.1523-1755.2005.00365.x","volume":"67","author":"AS Levey","year":"2005","unstructured":"Levey AS, Eckardt KU, Tsukamoto Y, et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2005;67:2089\u2013100.","journal-title":"Kidney Int"},{"issue":"5","key":"17_CR17","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/clpt.2009.124","volume":"86","author":"LA Stevens","year":"2009","unstructured":"Stevens LA, Levey AS. Use of the MDRD study equation to estimate kidney function for drug dosing. Clin Pharmacol Ther. 2009;86(5):465\u20137.","journal-title":"Clin Pharmacol Ther"},{"issue":"8","key":"17_CR18","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s00228-009-0678-8","volume":"65","author":"RK Verbeeck","year":"2009","unstructured":"Verbeeck RK, Musuamba FT. Pharmacokinetics and dosage adjustment in patients with renal dysfunction. Eur J Clin Pharmacol. 2009;65(8):757\u201377.","journal-title":"Eur J Clin Pharmacol"},{"issue":"12","key":"17_CR19","first-page":"597","volume":"30","author":"V Launay-Vacher","year":"2001","unstructured":"Launay-Vacher V, Storme T, Izzedine H, et al. Pharmacokinetic changes in renal failure. Presse Med. 2001;30(12):597\u2013604.","journal-title":"Presse Med"},{"issue":"986","key":"17_CR20","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1136\/pgmj.2007.063735","volume":"83","author":"N Thorogood","year":"2007","unstructured":"Thorogood N, Atwal S, Mills W, et al. The risk of antimalarials in patients with renal failure. Postgrad Med J. 2007;83(986):e8.","journal-title":"Postgrad Med J"},{"key":"17_CR21","unstructured":"Summary of product characteristics (SmPC) of Nivaquine\u00ae [in French]. http:\/\/agence-prd.ansm.sante.fr\/php\/ecodex\/rcp\/R0130632.htm . Accessed 8 Aug 2012."},{"issue":"2","key":"17_CR22","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0035-9203(88)90417-8","volume":"82","author":"E Stahel","year":"1988","unstructured":"Stahel E, Druilhe P, Gentilini M. Antagonism of chloroquine with other antimalarials. Trans R Soc Trop Med Hyg. 1988;82(2):221.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"17_CR23","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2165\/00003088-198510030-00001","volume":"10","author":"NJ White","year":"1985","unstructured":"White NJ. Clinical pharmacokinetics of antimalarial drugs. Clin Pharmacokinet. 1985;10:187\u2013215.","journal-title":"Clin Pharmacokinet"},{"issue":"3\u20134","key":"17_CR24","first-page":"177","volume":"13","author":"LA Salako","year":"1984","unstructured":"Salako LA, Walker O, Iyun AO. Pharmacokinetics of chloroquine in renal insufficiency. Afr J Med Med Sci. 1984;13(3\u20134):177\u201382.","journal-title":"Afr J Med Med Sci"},{"issue":"3","key":"17_CR25","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00007691-198609000-00008","volume":"8","author":"A Akintonwa","year":"1986","unstructured":"Akintonwa A, Odutola TA, Edeki T, et al. Hemodialysis clearance of chloroquine in uremic patients. Ther Drug Monit. 1986;8(3):285\u20137.","journal-title":"Ther Drug Monit"},{"key":"17_CR26","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1159\/000086591","volume":"25","author":"V Launay-Vacher","year":"2005","unstructured":"Launay-Vacher V, Izzedine H, Baumelou A, et al. FHD: an index to evaluate drug elimination by hemodialysis. Am J Nephrol. 2005;25:342\u201351.","journal-title":"Am J Nephrol"},{"issue":"1","key":"17_CR27","first-page":"43","volume":"16","author":"EM Chiluba","year":"1987","unstructured":"Chiluba EM, Fletcher KA, Price AH. The pharmacokinetics of proguanil in human subjects following a single oral dose. Afr J Med Med Sci. 1987;16(1):43\u20136.","journal-title":"Afr J Med Med Sci"},{"issue":"2","key":"17_CR28","first-page":"104","volume":"28","author":"JE Tattersall","year":"1987","unstructured":"Tattersall JE, Greenwood RN, Baker LR, et al. Proguanil poisoning in a hemodialysis patient. Clin Nephrol. 1987;28(2):104.","journal-title":"Clin Nephrol"},{"issue":"2","key":"17_CR29","first-page":"106","volume":"18","author":"M Boots","year":"1982","unstructured":"Boots M, Phillips M, Curtis JR. Megaloblastic anemia and pancytopenia due to proguanil in patients with chronic renal failure. Clin Nephrol. 1982;18(2):106\u20138.","journal-title":"Clin Nephrol"},{"issue":"1","key":"17_CR30","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1159\/000189512","volume":"75","author":"RA Sirsat","year":"1997","unstructured":"Sirsat RA, Dasgupta A. Haematological complications of proguanil in a patient with chronic renal failure. Nephron. 1997;75(1):108.","journal-title":"Nephron"},{"key":"17_CR31","unstructured":"Summary of product characteristics (SmPC) of Paludrine\u00ae [in French]. http:\/\/agence-prd.ansm.sante.fr\/php\/ecodex\/rcp\/R0207917.htm . Accessed 8 Aug 2012."},{"key":"17_CR32","unstructured":"Summary of product characteristics (SmPC) of Savarine\u00ae [in French]. http:\/\/agence-prd.ansm.sante.fr\/php\/ecodex\/rcp\/R0167697.htm . Accessed 8 Aug 2012."},{"key":"17_CR33","unstructured":"Summary of product characteristics (SmPC) of Malarone\u00ae [in French]. http:\/\/agence-prd.ansm.sante.fr\/php\/ecodex\/rcp\/R0173830.htm . Accessed 8 Aug 2012."},{"issue":"6","key":"17_CR34","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1128\/AAC.41.6.1319","volume":"41","author":"PE Rolan","year":"1997","unstructured":"Rolan PE, Mercer AJ, Tate E, et al. Disposition of atovaquone in humans. Antimicrob Agents Chemother. 1997;41(6):1319\u201321.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"17_CR35","doi-asserted-by":"crossref","first-page":"176","DOI":"10.2165\/00003495-199550010-00011","volume":"50","author":"CM Spencer","year":"1995","unstructured":"Spencer CM, Goa KL. Atovaquone: a review of its pharmacological properties and therapeutic efficacy in opportunistic infections. Drugs. 1995;50(1):176\u201396.","journal-title":"Drugs"},{"issue":"4","key":"17_CR36","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/infdis\/163.4.843","volume":"163","author":"WT Hughes","year":"1991","unstructured":"Hughes WT, Kennedy W, Shenep JL, et al. Safety and pharmacokinetics of 566C80, a hydroxynaphthoquinone with anti-pneumocystis carinii activity: a phase I study in human immunodeficiency virus (HIV)-infected men. J Infect Dis. 1991;163(4):843\u20138.","journal-title":"J Infect Dis"},{"key":"17_CR37","volume-title":"Drug prescribing in renal failure: dosing guidelines for adults and children","author":"GR Aronoff","year":"2007","unstructured":"Aronoff GR, Bennett WM, Berns JS, et al. Drug prescribing in renal failure: dosing guidelines for adults and children. 5th ed. Philadelphia: American College of Physicians; 2007.","edition":"5"},{"issue":"8","key":"17_CR38","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00228-010-0824-3","volume":"66","author":"H Jolink","year":"2010","unstructured":"Jolink H, den Hartigh J, Visser LG, et al. Pancytopenia due to proguanil toxicity in a returning traveller with fever. Eur J Clin Pharmacol. 2010;66(8):811\u20132.","journal-title":"Eur J Clin Pharmacol"},{"key":"17_CR39","unstructured":"Summary of product characteristics (SmPC) of Lariam\u00ae [in French]. http:\/\/agence-prd.ansm.sante.fr\/php\/ecodex\/rcp\/R0201777.htm . Accessed 8 Aug 2012."},{"key":"17_CR40","unstructured":"Development of mefloquine as an antimalarial drug. Bull World Health Organ. 1983;61(2):169\u2013178."},{"key":"17_CR41","volume-title":"GPR: antifongiques et antiparasitaires. Guide de prescription des m\u00e9dicaments chez le patient insuffisant r\u00e9nal","author":"V Launay-Vacher","year":"2002","unstructured":"Launay-Vacher V, Bassilios N, Deray G. GPR: antifongiques et antiparasitaires. Guide de prescription des m\u00e9dicaments chez le patient insuffisant r\u00e9nal. Paris: M\u00e9ditions International; 2002."},{"issue":"8","key":"17_CR42","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1128\/AAC.39.8.1892","volume":"39","author":"CA Crevoisier","year":"1995","unstructured":"Crevoisier CA, Joseph I, Fischer M, et al. Influence of hemodialysis on plasma concentration-time profiles of mefloquine in two patients with end-stage renal disease: a prophylactic monitoring study. Antimicrob Agents Chemother. 1995;39(8):1892\u20135.","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"17_CR43","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1128\/AAC.16.6.710","volume":"16","author":"RE Desjardins","year":"1979","unstructured":"Desjardins RE, Canfield CJ, Haynes JD, et al. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob Agents Chemother. 1979;16(6):710\u20138.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"17_CR44","doi-asserted-by":"crossref","first-page":"430","DOI":"10.2165\/00003495-199345030-00009","volume":"45","author":"KJ Palmer","year":"1993","unstructured":"Palmer KJ, Holliday SM, Brogden RN. Mefloquine: a review of its antimalarial activity, pharmacokinetic properties and therapeutic efficacy. Drugs. 1993;45(3):430\u201375.","journal-title":"Drugs"},{"key":"17_CR45","unstructured":"Summary of product characteristics (SmPC) of Vibramycin\u00ae [in French]. http:\/\/agence-prd.ansm.sante.fr\/php\/ecodex\/rcp\/R0173656.htm . Accessed 8 Aug 2012."},{"key":"17_CR46","volume-title":"GPR: antibact\u00e9riens. Guide de prescription des m\u00e9dicaments chez le patient insuffisant r\u00e9nal","author":"N Bassilios","year":"2002","unstructured":"Bassilios N, Launay-Vacher V, Deray G. GPR: antibact\u00e9riens. Guide de prescription des m\u00e9dicaments chez le patient insuffisant r\u00e9nal. Paris: M\u00e9ditions International; 2002."},{"issue":"17","key":"17_CR47","first-page":"593","volume":"101","author":"J Fabre","year":"1971","unstructured":"Fabre J, Milek EF, Kalfopoulos P, et al. Tetracycline kinetics in man: digestive absorption and serum concentration. Schweiz Med Wochenschr. 1971;101(17):593\u20138.","journal-title":"Schweiz Med Wochenschr"},{"issue":"5","key":"17_CR48","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/ki.1974.52","volume":"5","author":"A Whelton","year":"1974","unstructured":"Whelton A, Schach von Wittenau M, Twomey TM. Doxycycline pharmacokinetics in the absence of renal function. Kidney Int. 1974;5(5):365\u201371.","journal-title":"Kidney Int"},{"issue":"3","key":"17_CR49","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000221802","volume":"20","author":"NK Ao","year":"1974","unstructured":"Ao NK, Taneja OP, Bhatia VN, et al. Serum concentration and urinary excretion of doxycycline in normal subjects and patients with renal insufficiency. Chemotherapy. 1974;20(3):129\u201340.","journal-title":"Chemotherapy"},{"key":"17_CR50","first-page":"355","volume":"75","author":"P Lee","year":"1972","unstructured":"Lee P, Crutch ER, Morrison RB. Doxycycline: studies in normal subjects and patients with renal failure. N Z Med J. 1972;75:355\u20138.","journal-title":"N Z Med J"},{"issue":"1","key":"17_CR51","first-page":"49","volume":"34","author":"M Barza","year":"1977","unstructured":"Barza M, Schiefe RT. Antimicrobial spectrum, pharmacology and therapeutic use of antibiotics. Part I: tetracyclines. Am J Hosp Pharm. 1977;34(1):49\u201357.","journal-title":"Am J Hosp Pharm"},{"issue":"3","key":"17_CR52","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1365-2125.1983.tb02157.x","volume":"16","author":"G Houin","year":"1983","unstructured":"Houin G, Brunner F, Nebout T, et al. The effects of chronic renal insufficiency on the pharmacokinetics of doxycycline in man. Br J Clin Pharmacol. 1983;16(3):245\u201352.","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"17_CR53","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/BF01060035","volume":"1","author":"JM Jaffe","year":"1973","unstructured":"Jaffe JM, Colaizzi JL, Poust RI, et al. Effect of altered urinary pH on tetracycline and doxycycline excretion in humans. J Pharmacokinet Biopharm. 1973;1(4):267\u201382.","journal-title":"J Pharmacokinet Biopharm"},{"issue":"4","key":"17_CR54","doi-asserted-by":"crossref","first-page":"294","DOI":"10.7326\/0003-4819-120-4-199402150-00006","volume":"120","author":"MJ Shmuklarsky","year":"1994","unstructured":"Shmuklarsky MJ, Boudreau EF, Pang LW, et al. Failure of doxycycline as a causal prophylactic agents against Plasmodium falciparum malaria in healthy non immune volunteers. Ann Intern Med. 1994;120(4):294\u20139.","journal-title":"Ann Intern Med"},{"key":"17_CR55","unstructured":"Institut de veille Sanitaire. Health recommendations for travellers, 2012. Bulletin \u00e9pid\u00e9miologique hebdomadaire no 20\u201321, 2012. http:\/\/www.invs.sante.fr\/Publications-et-outils\/BEH-Bulletin-epidemiologique-hebdomadaire\/Derniers-numeros-et-archives\/Archives\/2012\/BEH-n-20-21-20122 . Accessed 27 Dec 2012."},{"key":"17_CR56","unstructured":"Centers for Disease Control and Prevention. Malaria information and prophylaxis, by country. http:\/\/www.cdc.gov\/malaria\/travelers\/country_table\/t.html . Accessed 14 Jan 2013."}],"container-title":["Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-013-0017-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40264-013-0017-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-013-0017-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T22:47:01Z","timestamp":1562626021000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40264-013-0017-y"}},"subtitle":["A Review"],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":56,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["17"],"URL":"https:\/\/doi.org\/10.1007\/s40264-013-0017-y","relation":{},"ISSN":["0114-5916","1179-1942"],"issn-type":[{"value":"0114-5916","type":"print"},{"value":"1179-1942","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}